Freeline Therapeutics Holdings plc Share-based Payment Arrangement, Expense
Freeline Therapeutics Holdings plc reported Share-based Payment Arrangement, Expense of $2.94 million for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-12-01
- Freeline Therapeutics Holdings plc share-based payment arrangement, expense for the quarter ending 2023-09-30 was $895.00K, a 25.54% decline year-over-year.
- Freeline Therapeutics Holdings plc share-based payment arrangement, expense for the quarter ending 2023-06-30 was $1.07M, a 26.32% decline year-over-year.
- Freeline Therapeutics Holdings plc share-based payment arrangement, expense for the quarter ending 2023-03-31 was $973.00K, a 29.29% decline year-over-year.
- Freeline Therapeutics Holdings plc share-based payment arrangement, expense for the quarter ending 2022-12-31 was $1.04M, a 43.91% decline year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $895.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | $1.97M derived: sum of 2 quarters · filed 2023-12-01 | $2.94M 6-K · filed 2023-12-01 | $3.98M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-06-30 | $1.07M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $2.05M 6-K · filed 2023-08-15 | $3.09M derived: sum of 3 quarters · filed 2023-08-15 | $4.29M derived: sum of 4 quarters · filed 2023-12-01 |
| 2023-03-31 | $973.00K 6-K · filed 2023-05-30 | $2.01M derived: sum of 2 quarters · filed 2023-05-30 | $3.21M derived: sum of 3 quarters · filed 2023-12-01 | $4.67M derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-12-31 | $1.04M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $2.24M derived: sum of 2 quarters · filed 2023-12-01 | $3.70M derived: sum of 3 quarters · filed 2023-12-01 | $5.08M 20-F · filed 2023-04-04 |
| 2022-09-30 | $1.20M derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | $2.66M derived: sum of 2 quarters · filed 2023-12-01 | $4.04M 6-K · filed 2023-12-01 | $5.89M derived: sum of 4 quarters · filed 2023-12-01 |
| 2022-06-30 | $1.46M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $2.83M 6-K · filed 2023-08-15 | $4.69M derived: sum of 3 quarters · filed 2023-08-15 | $7.87M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | $1.38M 6-K · filed 2023-05-30 | $3.23M derived: sum of 2 quarters · filed 2023-05-30 | $6.41M derived: sum of 3 quarters · filed 2023-05-30 | $9.55M derived: sum of 4 quarters · filed 2023-05-30 |
| 2021-12-31 | $1.85M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $5.04M derived: sum of 2 quarters · filed 2023-04-04 | $8.18M derived: sum of 3 quarters · filed 2023-04-04 | $10.72M 20-F · filed 2023-04-04 |
| 2021-09-30 | $3.18M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | $6.32M derived: sum of 2 quarters · filed 2022-11-15 | $8.87M 6-K · filed 2022-11-15 | $11.24M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-06-30 | $3.14M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $5.69M 6-K · filed 2022-08-09 | $8.06M derived: sum of 3 quarters · filed 2023-04-04 | $11.32M derived: sum of 4 quarters · filed 2023-04-04 |
| 2021-03-31 | $2.55M 6-K · filed 2022-05-10 | $4.92M derived: sum of 2 quarters · filed 2023-04-04 | $8.18M derived: sum of 3 quarters · filed 2023-04-04 | $8.42M derived: sum of 4 quarters · filed 2023-04-04 |
| 2020-12-31 | $2.37M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04 | $5.64M derived: sum of 2 quarters · filed 2023-04-04 | $5.87M derived: sum of 3 quarters · filed 2023-04-04 | $6.20M 20-F · filed 2023-04-04 |
| 2020-09-30 | $3.26M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $3.50M derived: sum of 2 quarters · filed 2021-11-09 | $3.83M 6-K · filed 2021-11-09 | |
| 2020-06-30 | $238.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16 | $568.00K 6-K · filed 2021-08-16 | ||
| 2020-03-31 | $330.00K 6-K · filed 2021-05-17 | |||
| 2019-12-31 | $1.46M 20-F · filed 2022-03-31 | |||
| 2019-06-30 | $216.00K 6-K · filed 2020-10-29 | |||
| 2018-12-31 | $114.00K 20-F · filed 2021-03-31 |